Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain–Barré Syndrome

Hartung, 1991, Immune activation in Guillain–Barré Syndrome: cytokine studies, Ann Neurol, 30, 304 Hartung, 1993, Immune-mediated demyelination, Ann. Neurol, 33, 563, 10.1002/ana.410330602 Hartung, 1994, Experimental allergic neuritis and Guillain–Barré Syndrome: immune mechanisms. A short review, Acta Neurol Belg, 94, 120 Hohnoki, 1998, Elevated serum levels of IFN-γ, IL-4 and TNF-α, unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage, J Neuroimmunol, 87, 27, 10.1016/S0165-5728(98)00053-8 Feasby, 1987, An acute axonal form of Guillain–Barré polyneuropathy, Brain, 109, 1115, 10.1093/brain/109.6.1115 Griffin, 1995, Guillain–Barré Syndrome in Northern China. The spectrum of neuropathological changes in clinically defined cases, Brain, 11, 577, 10.1093/brain/118.3.577 Ho, 1995, Guillain–Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies, Brain, 118, 597, 10.1093/brain/118.3.597 Oomes, 1995, Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain–Barré Syndrome. Evidence of molecular mimicry, Ann Neurol, 38, 170, 10.1002/ana.410380208 Illa, 1995, Acute axonal Guillain–Barré syndrome with antibodies against motor axons following parenteral gangliosides, Ann Neurol, 38, 218, 10.1002/ana.410380214 Schmidt, 1992, Transient cellular expression of gamma-interferon in myelin-induced and T-cell line-mediated experimental autoimmune neuritis, Brain, 115, 1633, 10.1093/brain/115.6.1633 Jung, 1994, Therapeutic effect of transforming factor type-beta 2 on actively induced EAN but not adoptive transfer EAN, Immunology, 83, 545 Gallo, 1994, Intrathecal synthesis of interleukin 10 (IL-10) in viral and inflammatory diseases of the central nervous system, J Neurol Sci, 126, 49, 10.1016/0022-510X(94)90093-0 Gregorian, 1994, Delayed-type hypersensitivity response in experimental allergic neuritis treated with peptide-coupled spleen cells, Neuroimmunology, 51, 69, 10.1016/0165-5728(94)90130-9 Gregorian, 1994, Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1, Cell Immunol, 156, 102, 10.1006/cimm.1994.1156 Lisak, 1997, The role of cytokines in Schwann cell damage, protection and repair, J Infect Dis, 176, S173, 10.1086/513788 Koski, 1997, Mechanisms of Schwann cell damage in inflammatory neuropathy, J Infect Dis, 176, S169, 10.1086/513795 Zhu, 1998, Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain–Barré syndrome, J Neuroimmunol, 84, 40, 10.1016/S0165-5728(97)00238-5 Koski, 1990, Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain–Barré Syndrome, Ann. Neurol, 27, S44, 10.1002/ana.410270712 Hafer-Macko, 1996, Immune attack on the Schwann Cell surface in acute inflammatory demyelinating polyneuropathy, Ann Neurol, 309, 625, 10.1002/ana.410390512 Makgoba, 1989, The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition, Immunology Today, 10, 417, 10.1016/0167-5699(89)90039-X Archelos, 1993, Suppression of experimental allergic neuritis by an antibody to the intercellular adhesion molecule ICAM-1, Brain, 116, 1043, 10.1093/brain/116.5.1043 Hartung, 1990, The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system, Ann Neurol, 27, 247, 10.1002/ana.410270306 Sharief, 1993, Elevated serum levels of tumor necrosis factor-α in Guillain–Barré Syndrome, Ann Neurol, 33, 591, 10.1002/ana.410330606 Sharief, 1997, Circulating TNF-α correlates with electrodiagnostic abnormalities in Guillain–Barré syndrome, Ann Neurol, 42, 68, 10.1002/ana.410420112 Springer, 1990, Adhesion receptors of the immune system, Nature, 346, 425, 10.1038/346425a0 Hartung, 1995, Circulating adhesion molecules and inflammatory mediators in demyelination: a review, Neurology, 45, S22, 10.1212/WNL.45.6_Suppl_6.S22 Bansil, 1992, Elevated neopterin levels in Guillain–Barré Syndrome. Further evidence of immune activation, Arch. Neurol, 49, 1277, 10.1001/archneur.1992.00530360079021 Exley, 1994, Tumor necrosis factor-alpha and other cytokines in Guillain–Barré Syndrome, J Neurol Neurosurg Psychiatry, 57, 1118, 10.1136/jnnp.57.9.1118 Mithen, 1990, Human alpha tumor necrosis factor does not damage cultures containing rat Schwann cells and sensory neurons, Neurosci Res, 9, 59, 10.1016/0168-0102(90)90046-H Wagner, 1996, Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves, Neuroscience, 73, 625, 10.1016/0306-4522(96)00127-3 Jenkins, 1992, Tumor necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve, J Neurol Sci, 108, 99, 10.1016/0022-510X(92)90194-P Said, 1992, Nerve lesion induced by macrophage activation, Res Immunol, 143, 589, 10.1016/0923-2494(92)80040-R Sorkin, 1997, Tumor necrosis factor alpha induces ectopic activity in nociceptive primary afferent fibres, Neuroscience, 81, 255, 10.1016/S0306-4522(97)00147-4 Lisak, 1998, Inflammatory cytokines inhibit upregulation of glylipid expression by Schwann cells in vitro, Neurology, 51, 1661, 10.1212/WNL.51.6.1661 Lichtenfeld, 1971, Autonomic dysfunction in the Guillain–Barré Syndrome, Am J Med, 50, 772, 10.1016/0002-9343(71)90185-9